Cargando…

Iron Chelator Deferoxamine Alleviates Progression of Diabetic Nephropathy by Relieving Inflammation and Fibrosis in Rats

Diabetic nephropathy (DN) is one of the most devastating diabetic microvascular complications. It has previously been observed that iron metabolism levels are abnormal in diabetic patients. However, the mechanism by which iron metabolism levels affect DN is poorly understood. This study was designed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yunfei, Jia, Li, Ma, Wan, Tian, Chenying, Du, Huahua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452339/ https://www.ncbi.nlm.nih.gov/pubmed/37627331 http://dx.doi.org/10.3390/biom13081266

Ejemplares similares

The iron chelator deferoxamine decreases myeloma cell survival
por: Yang, Feifei, et al.
Publicado: (2021)

Iron Chelation by Deferoxamine Prevents Renal Interstitial Fibrosis in Mice with Unilateral Ureteral Obstruction
por: Ikeda, Yasumasa, et al.
Publicado: (2014)

Chelation of gadolinium with deferoxamine in a patient with nephrogenic systemic fibrosis
por: Leung, Nelson, et al.
Publicado: (2009)

Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
por: Ansari, Shahla, et al.
Publicado: (2017)

Iron chelation cancer therapy using hydrophilic block copolymers conjugated with deferoxamine
por: Komoto, Kana, et al.
Publicado: (2020)

Model-Based Optimisation of Deferoxamine Chelation Therapy
por: Bellanti, Francesco, et al.
Publicado: (2015)

Formulation and In-Vitro Characterization of Chitosan-Nanoparticles Loaded with the Iron Chelator Deferoxamine Mesylate (DFO)
por: Lazaridou, Maria, et al.
Publicado: (2020)

Comparison Between Hesperidin, Coumarin, and Deferoxamine Iron Chelation and Antioxidant Activity Against Excessive Iron in the Iron Overloaded Mice
por: Aalikhani, Mahdi, et al.
Publicado: (2022)

Chelating the valley of death: Deferoxamine’s path from bench to wound clinic
por: Parker, Jennifer B., et al.
Publicado: (2023)

Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator
por: Bellotti, Denise, et al.
Publicado: (2021)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
por: Taher, Ali T, et al.
Publicado: (2016)

Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
por: Hassan, Mohamed Abdel Malik, et al.
Publicado: (2016)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
por: Kontoghiorghe, Christina N, et al.
Publicado: (2016)

Baicalin and deferoxamine alleviate iron accumulation in different brain regions of Parkinson's disease rats★
por: Xiong, Pei, et al.
Publicado: (2012)

An iron chelation-based combinatorial anticancer therapy comprising deferoxamine and a lactate excretion inhibitor inhibits the proliferation of cancer cells
por: Fujisawa, Koichi, et al.
Publicado: (2022)

Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage
por: Li, Zhe, et al.
Publicado: (2022)

Emerging Roles of the Iron Chelators in Inflammation
por: Di Paola, Alessandra, et al.
Publicado: (2022)

Comparison of the effects of deferasirox, deferoxamine, and combination of deferasirox and deferoxamine on an aplastic anemia mouse model complicated with iron overload
por: Wu, Dijiong, et al.
Publicado: (2018)

Deferoxamine inhibition of malaria is independent of host iron status
Publicado: (1988)

Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

Deferoxamine Reduces Inflammation and Osteoclastogenesis in Avulsed Teeth
por: Lee, Ko Eun, et al.
Publicado: (2021)

Secondary iron overload induces chronic pancreatitis and ferroptosis of acinar cells in mice
por: Tian, Chenying, et al.
Publicado: (2022)

Abstract 1: Transdermal Deferoxamine Alleviates Radiation-Induced Damage In Porcine Skin
por: Adem, Sandeep, et al.
Publicado: (2020)

Abstract 129: Transdermal Deferoxamine Mitigates Radiation-induced Skin Fibrosis
por: Borrelli, Mimi R., et al.
Publicado: (2020)

Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022)

Correction: Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine
por: Chen, Jianfang, et al.
Publicado: (2013)

Testing of the siderophore deferoxamine amended in hydrogels for the cleaning of iron corrosion
por: Cuvillier, Luana, et al.
Publicado: (2023)

Prophylactic treatment with transdermal deferoxamine mitigates radiation-induced skin fibrosis
por: Shen, Abra H., et al.
Publicado: (2020)

Regulation of a High-Iron Diet on Lipid Metabolism and Gut Microbiota in Mice
por: Xiong, Qingqing, et al.
Publicado: (2022)

Deferasirox, an iron-chelating agent, alleviates acute lung inflammation by inhibiting neutrophil activation and extracellular trap formation
por: Kono, Mari, et al.
Publicado: (2020)

PEGylation of Deferoxamine for Improving the Stability, Cytotoxicity, and Iron-Overload in an Experimental Stroke Model in Rats
por: Xu, Jiake, et al.
Publicado: (2020)

A comparative analysis of deferoxamine treatment modalities for dermal radiation‐induced fibrosis
por: Lavin, Christopher V., et al.
Publicado: (2021)

Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
por: Guo, Zhou, et al.
Publicado: (2022)

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)

In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab
por: Roy, Jyoti, et al.
Publicado: (2021)

Re: “Protective Role of Silymarin and Deferoxamine against Iron Dextran-Induced Renal Iron Deposition in Male Rats,” and “Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model”
por: Mazaheri, Safoora, et al.
Publicado: (2014)

Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice
por: Yan, Hong-Fa, et al.
Publicado: (2018)

Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway
por: Guo, Zhou, et al.
Publicado: (2023)

Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression
por: Mertens, Christina, et al.
Publicado: (2016)

Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats
por: Nematbakhsh, Mehdi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lgjppr2pcqph9efsn9o9on63pk